Ironwood Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
On the Specialty Pharmaceuticals pack for the day, it's my pleasure to have the management team from Ironwood with us. With me, I have Sravan Emany, the CFO; and Mike Shetzline, the Chief Medical Officer. And my name is Balaji Prasad, so I lead the specialty pharmaceuticals coverage for Barclays. Sravan and Mike, thank you for taking the time today to be with us. It's great to do it in person too, so.
Absolutely.
Questions & Answers
So let me first start with the core franchise rights, LINZESS. It continues to perform very well. It's near tenth year since you launched, and now we have guided to double-digit demand growth, prescription demand growth. So what's driving this trend? And how confident are you of ensuring that this is sustainable. And of course, I -- my apologies also if you have an opening
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |